The half-life of injectable BPC-157 is estimated to be a few hours , though exact figures vary depending on the delivery method: Injectable BPC-157: Rapid absorption and clearance, typically 46 hours Oral capsules or sublingual forms: May have extended release times, but reduced bioavailability This means BPC-157 itself doesnt accumulate in your system over timebut the regenerative effects it stimulates (like collagen production and angiogenesis) can continue long after dosing ends
Presented for research literature review only PATTERSON JW et al
Units are volume markings (1 unit = 0.01 mL on a U-100 syringe), never doses
Nutrients 4(10):13991440 Klepac N, Relja M, Klepac R, Heimovi S, Babi T, Trkulja V (2007) Oxidative stress parameters in plasma of Huntingtons disease patients, asymptomatic Huntingtons disease gene carriers and healthy subjects
It may also lead to more serious side effects
(Particle Peptides) Chronic disease and degenerative conditions Senescent cells play a role in osteoarthritis, kidney disease, cardiovascular disease, lung fibrosis, perhaps neurodegeneration (via chronic SASP)